Intravacc reports positive data from Phase I trial of RSV vaccine

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorised blue). Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH).



  • Intravacc; RSV vaccine